98 related articles for article (PubMed ID: 33165811)
1. Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53.
Liu X; Zhang L; Thu PM; Min W; Yang P; Li J; Li P; Xu X
Sci China Life Sci; 2021 Aug; 64(8):1295-1310. PubMed ID: 33165811
[TBL] [Abstract][Full Text] [Related]
2. Experimental study on the inhibitory effect of sodium cantharidinate on human hepatoma HepG2 cells.
Wen SQ; Chen Q; Hu M
Afr J Tradit Complement Altern Med; 2014; 11(1):131-4. PubMed ID: 24653566
[TBL] [Abstract][Full Text] [Related]
3. Sodium cantharidinate induces HepG2 cell apoptosis through LC3 autophagy pathway.
Tao R; Sun WY; Yu DH; Qiu W; Yan WQ; Ding YH; Wang GY; Li HJ
Oncol Rep; 2017 Aug; 38(2):1233-1239. PubMed ID: 28677738
[TBL] [Abstract][Full Text] [Related]
4. Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway.
Zheng C; Jia W; Tang Y; Zhao H; Jiang Y; Sun S
J Exp Clin Cancer Res; 2012 Oct; 31(1):84. PubMed ID: 23034174
[TBL] [Abstract][Full Text] [Related]
5. Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway.
Park M; Upton D; Blackmon M; Dixon V; Craver S; Neal D; Perkins D
BMC Complement Altern Med; 2018 Feb; 18(1):71. PubMed ID: 29463243
[TBL] [Abstract][Full Text] [Related]
6. Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: implications of IL-6/JAK2/STAT3 and p53/caspases-dependent signaling pathways based on molecular docking and in vitro study.
Tantawy MA; El-Sherbeeny NA; Helmi N; Alazragi R; Salem N; Elaidy SM
Mol Cell Biochem; 2020 Jun; 469(1-2):143-157. PubMed ID: 32356241
[TBL] [Abstract][Full Text] [Related]
7. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
[TBL] [Abstract][Full Text] [Related]
8. Sodium cantharidate induces Apoptosis in breast cancer cells by regulating energy metabolism via the protein phosphatase 5-p53 axis.
Pang JL; Huang FH; Zhang YH; Wu Y; Ge XM; Li S; Li X
Toxicol Appl Pharmacol; 2021 Nov; 430():115726. PubMed ID: 34537213
[TBL] [Abstract][Full Text] [Related]
9. [Study on synergistic effect of sodium cantharidinate combined with chemotherapeutic drugs on hepatic carcinoma and its effective mechanism].
Zhao RL; Chen MJ; Zhao FM; Xu DQ; Zhang X; Zhou KF
Zhong Yao Cai; 2014 Nov; 37(11):1938-46. PubMed ID: 26027111
[TBL] [Abstract][Full Text] [Related]
10. [Effect of sodium cantharidinate on the angiogenesis of nude mice with human gastric cancer].
Liang F; Wang MY; Huang WB; Li AJ
Zhong Yao Cai; 2011 Mar; 34(3):343-6. PubMed ID: 21823448
[TBL] [Abstract][Full Text] [Related]
11. Combination of Sodium Cantharidinate with Cisplatin Synergistically Hampers Growth of Cervical Cancer.
Chen X; Zhou M; Fan W; Yang M; Yang L
Drug Des Devel Ther; 2021; 15():171-183. PubMed ID: 33469269
[TBL] [Abstract][Full Text] [Related]
12. [Combination of triptolide with sodium cantharidinate synergistically enhances apoptosis on
hepatoma cell line 7721].
Zhou Y; Wang M; Pan X; Dong Z; Han L; Ju Y; Wang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):911-7. PubMed ID: 27640789
[TBL] [Abstract][Full Text] [Related]
13. MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53.
Canner JA; Sobo M; Ball S; Hutzen B; DeAngelis S; Willis W; Studebaker AW; Ding K; Wang S; Yang D; Lin J
Br J Cancer; 2009 Sep; 101(5):774-81. PubMed ID: 19707204
[TBL] [Abstract][Full Text] [Related]
14. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
Bi YL; Min M; Shen W; Liu Y
Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
[TBL] [Abstract][Full Text] [Related]
15. Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2/Bax.
Tian X; Zeng G; Li X; Wu Z; Wang L
Oncol Rep; 2015 Jun; 33(6):3061-8. PubMed ID: 25962755
[TBL] [Abstract][Full Text] [Related]
16. Trichodermin induces c-Jun N-terminal kinase-dependent apoptosis caused by mitotic arrest and DNA damage in human p53-mutated pancreatic cancer cells and xenografts.
Chien MH; Lee TH; Lee WJ; Yeh YH; Li TK; Wang PC; Chen JJ; Chow JM; Lin YW; Hsiao M; Wang SW; Hua KT
Cancer Lett; 2017 Mar; 388():249-261. PubMed ID: 27965041
[TBL] [Abstract][Full Text] [Related]
17. The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent.
Zhang Q; Wang H; Ran L; Zhang Z; Jiang R
Biochem Biophys Res Commun; 2016 Aug; 476(4):260-266. PubMed ID: 27233611
[TBL] [Abstract][Full Text] [Related]
18. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
19. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
20. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.
Shi Y; Sahu RP; Srivastava SK
BMC Cancer; 2008 Oct; 8():294. PubMed ID: 18847491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
